This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coon, J. S. Articles by Weinstein, R. S. Search for Related Content PubMed PubMed Citation Articles by Coon, J. S. Articles by Weinstein, R. S.

Solutol HS 15, Nontoxic Polyoxyethylene Esters of 12-Hydroxystearic Acid, Reverses Multidrug Resistance¹

Departments of Pathology [J. S. C., W. K., K. C., B. L., R. S. W], General Surgery [J. S. C.], and Biochemistry [W. K.], Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612

A recently developed non-ionic surfactant called Solutol HS 15 (polyoxyethylene esters of 12-hydroxystearic acid), with low toxicity in vivo, was shown to reverse completely the multidrug resistance of KB 8-5 and KB 8-5-11 human epidermoid carcinoma cells in vitro but did not potentiate drug toxicity in drug-sensitive KB 3-1 cells. At a concentration of 10% of its own IC₅₀ (mean concentration of drug that causes 50% inhibition of cell growth compared to controls), Solutol HS 15 produced a 35-, 28-, and 42-fold reduction in the resistance of KB 8-5-11 cells to colchicine, vinblastine, and doxorubicin, respectively. Solutol HS 15 was relatively much more potent than the prototypic reversing agent, verapamil, for reversing colchicine resistance, compared to the ability of each agent to reverse vinblastine resistance. Like verapamil, Solutol HS 15 promoted a 50-fold accumulation of rhodamine 123 in KB 8-5-11 cells, as measured by flow cytometry. Also, Solutol HS 15 and verapamil reduced the efflux of rhodamine 123 from KB 8-5-11 cells previously loaded with rhodamine 123 to a similar low rate. Solutol HS 15 did not affect the transport of alanine or glucose into KB 8-5-11 cells, indicating that its effect upon membrane active transport is not entirely nonspecific. Considering their different structure and different relative potency for reversing colchicine resistance, Solutol HS 15 and verapamil probably reverse multidrug resistance by different mechanisms. Solutol HS 15 merits consideration as a potential therapeutic agent because of its effectiveness for reversing multidrug resistance in vitro and its low toxicity in vivo.

¹ Supported by the Rayman Research Fund and the Otho Sprague Fund.

² To whom requests for reprints should be addressed.

Received 6/ 4/90. Accepted 11/19/90.

This article has been cited by other articles:

				E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J.-P. Benoit A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol. Cancer Ther., July 1, 2006; 5(7): 1710 - 1722. [Abstract] [Full Text] [PDF]

				J. J. Ley, A. Vigdorchik, L. Belayev, W. Zhao, R. Busto, L. Khoutorova, D. A. Becker, and M. D. Ginsberg Stilbazulenyl Nitrone, a Second-Generation Azulenyl Nitrone Antioxidant, Confers Enduring Neuroprotection in Experimental Focal Cerebral Ischemia in the Rat: Neurobehavior, Histopathology, and Pharmacokinetics J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1090 - 1100. [Abstract] [Full Text] [PDF]

				J. H. M. Charuk, A. A. Grey, and R. A. F. Reithmeier Identification of the synthetic surfactant nonylphenol ethoxylate: a P-glycoprotein substrate in human urine Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1127 - F1139. [Abstract] [Full Text] [PDF]